Amy Zhang serves as the portfolio manager for the Alger Mid Cap Focus Fund and has been managing the strategy since 2019. The broader Alger investment team is led by Daniel C. Chung as Chief Executive Officer, Chief Investment Officer and Portfolio Manager, who joined Alger in 1994 and brings 31 years of investment experience. Patrick Kelly serves as Executive Vice President, Portfolio Manager, and Head of Cap Appreciation & Spectra Strategies with 27 years of experience and CFA designation.

Read More

The fund seeks long-term capital appreciation and invests in a focused portfolio of approximately 50 holdings of primarily mid cap companies identified through fundamental research. The investment process focuses on companies demonstrating Positive Dynamic Change, defined as companies experiencing high unit volume growth or positive lifecycle change including regulatory changes, new products, and management shifts. Under normal circumstances, the fund invests at least 80% of its net assets in equity securities of mid-cap companies with market capitalizations between $1 billion and $30 billion. The approach is based on independent, creative, bottom-up, fundamental research utilizing proprietary tools including the Alger Rating System and Alger Psych Line. The fund maintains a minimum 25% focus on industries such as Health Care Equipment & Supplies, Health Care Technology, Biotechnology, Life Sciences Tools & Services, and Software.

Read More